Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Mikaela Naylon Give Kids a Chance Act
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
Mikaela Naylon Give Kids a Chance Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE HS COALITION via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
S.864, Help Ensure Lower Patient (HELP) Copays Act H. Res 484, Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2025 · second_quarter · 2T
Source: Senate LDA
| SOLENO THERAPEUTICS INC |
| 4 |
| 2024–2025 |
| ATAI LIFE SCIENCES N.V. | 3 | 2021–2022 |
| THE HS COALITION | 3 | 2025 |
| AEGLEA BIOTHERAPEUTICS, INC. | 2 | 2021 |
| FULCRUM THERAPEUTICS, INC. | 2 | 2024 |
| OPIANT PHARMACEUTICALS | 2 | 2021–2022 |
| PHARMAESSENTIA CORPORATION | 2 | 2021 |
| REZOLUTE | 2 | 2025 |
| ROCKET PHARMACEUTICALS INC. | 2 | 2024 |
| THE BRAIN DONOR PROJECT | 2 | 2021 |
| ULTRAGENYX PHARMACEUTICAL | 2 | 2021 |
| ZAMBON USA | 2 | 2021 |
| CHIESI USA INC | 1 | 2021 |
| COGNOA, INC. | 1 | 2021 |
| INOZYME PHARMA | 1 | 2025 |
| RELMADA THERAPEUTICS, INC. | 1 | 2021 |
Mikaela Naylon Give Kids a Chance Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
Mikaela Naylon Give Kids a Chance Act
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INOZYME PHARMA · Firm: THE KPM GROUP DC LLC
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
Accelerating Kids’ Access to Care Act of 2025
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act of 2025
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act of 2025
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act of 2025
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. · Firm: THE KPM GROUP DC LLC
H.R.2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week".
Client: THE HS COALITION · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H. Res 484, Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week"
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
Accelerating Kids’ Access to Care Act
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
S.864, Help Ensure Lower Patient (HELP) Copays Act H. Res 484, Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week"
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
S.4426, Promising Pathway Act 2.0 (118th Congress)
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Healthy Dog Importation Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Medicaid VBPs for Patients Act
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Medicaid VBPs for Patients Act
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Sickle Cell Care Expansion Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Give Kids a Chance Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
Give Kids a Chance Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Support for Patients and Communities Reauthorization Act
Client: NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. · Firm: THE KPM GROUP DC LLC
H.R.4531 - Support for Patients and Communities Reauthorization Act
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
Accelerating Kids’ Access to Care Act
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 7384/S.4583, Creating Hope Reauthorization Act H.R.4758/S.2372, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Accelerating Kids’ Access to Care Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0 H.R. 4758, Accelerating Kids Access to Care Act H.R. 6664, Innovation in Pediatric Drugs Act of 2023
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Innovation in Pediatric Drugs Act of 2023
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0 H.R. 4758, Accelerating Kids Access to Care Act H.R. 6664, Innovation in Pediatric Drugs Act of 2023
Innovation in Pediatric Drugs Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Innovation in Pediatric Drugs Act of 2023
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Creating Hope Reauthorization Act of 2024
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Creating Hope Reauthorization Act of 2024
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0
Creating Hope Reauthorization Act of 2024
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Creating Hope Reauthorization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
Creating Hope Reauthorization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act
Creating Hope Reauthorization Act of 2024
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 7384/S.4583, Creating Hope Reauthorization Act H.R.4758/S.2372, Accelerating Kids Access to Care Act
Creating Hope Reauthorization Act of 2024
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Creating Hope Reauthorization Act of 2024
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Creating Hope Reauthorization Act of 2024
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Creating Hope Reauthorization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0 H.R. 4758, Accelerating Kids Access to Care Act H.R. 6664, Innovation in Pediatric Drugs Act of 2023
Creating Hope Reauthorization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
Sickle Cell Disease Comprehensive Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Sickle Cell Disease Comprehensive Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Telehealth Modernization Act of 2024
Client: NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. · Firm: THE KPM GROUP DC LLC
H.R. 7623, Telehealth Modernization Act
Telehealth Modernization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. · Firm: THE KPM GROUP DC LLC
H.R.9029 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Patient Access Act of 2024
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Patient Access Act of 2024
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Expressing support for the designation of June 20, 2024, as "World FSHD Day".
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Expressing support for the designation of June 20, 2024, as "World FSHD Day".
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Veterans’ True Choice Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Accelerating Kids’ Access to Care Act
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 7384/S.4583, Creating Hope Reauthorization Act H.R.4758/S.2372, Accelerating Kids Access to Care Act
Accelerating Kids’ Access to Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Accelerating Kids’ Access to Care Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
Accelerating Kids’ Access to Care Act
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Office of Colonias and Farmworker Initiatives Establishment Act of 2024
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0 H.R. 4758, Accelerating Kids Access to Care Act H.R. 6664, Innovation in Pediatric Drugs Act of 2023
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0
Creating Hope Reauthorization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
Creating Hope Reauthorization Act of 2024
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Creating Hope Reauthorization Act of 2024
Client: PRAXIS PRECISION MEDICINES · Firm: THE KPM GROUP DC LLC
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
Creating Hope Reauthorization Act of 2024
Client: ROCKET PHARMACEUTICALS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Creating Hope Reauthorization Act of 2024
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Creating Hope Reauthorization Act of 2024
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 7384/S.4583, Creating Hope Reauthorization Act H.R.4758/S.2372, Accelerating Kids Access to Care Act
Discussed potential legislation to raise the reimbursement rate for mental health counselors in Medicare and SAMHSAs Minority Fellowship Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
S.4426, Promising Pathway Act 2.0 (118th Congress)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEBELA PHARMACEUTICALS via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
Requesting CMS change guidance on Bowel Prep Coverage for Screening Colonoscopies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2025 · second_quarter · RA
FDA Issues and health care reform
THE HS COALITION via THE KPM GROUP DC LLC
2025 · second_quarter · RA
General HS awareness HS research funding Medicare - Telehealth; Step Therapy/Prior Authorization in Part C and Part D
General HS awareness HS research funding Medicare - Telehealth; Step Therapy/Prior Authorization in Part C and Part D
INOZYME PHARMA via THE KPM GROUP DC LLC
2025 · second_quarter · RR
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
THE HS COALITION via THE KPM GROUP DC LLC
2025 · first_quarter · RR
General HS awareness HS research funding Medicare - Telehealth; Step Therapy/Prior Authorization in Part C and Part D
General HS awareness HS research funding Medicare - Telehealth; Step Therapy/Prior Authorization in Part C and Part D
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2025 · first_quarter · Q1
H.R.2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2025 · first_quarter · Q1
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2025 · first_quarter · Q1
H.R.1262/S.932, Give Kids a Chance Act H.R.1509/S.752, Accelerating Kids Access to Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEBELA PHARMACEUTICALS via THE KPM GROUP DC LLC
2025 · first_quarter · Q1
Discussed the need for Congressional oversight of CMS to ensure enforcement of the preventive services mandate, specifically requiring coverage of bowel preparation medications without cost-sharing when used for colonoscopy screenings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCKET PHARMACEUTICALS, INC. via THE KPM GROUP DC LLC
2024 · fourth_quarter · 4A
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCKET PHARMACEUTICALS, INC. via THE KPM GROUP DC LLC
2024 · fourth_quarter · RR
H.R.7384/S.4583, Creating Hope Reauthorization Act H.R.2666/S.4204, Medicaid VBPs for Patients (MVP) Act H.R.9184, Patient Access Act of 2024
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2024 · fourth_quarter · Q4
H.R. 7384/S.4583, Creating Hope Reauthorization Act H.R.4758/S.2372, Accelerating Kids Access to Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEBELA PHARMACEUTICALS via THE KPM GROUP DC LLC
2024 · fourth_quarter · Q4
The Affordable Care Acts Preventive Services Coverage mandate requires ACA-compliant health plans to cover colonoscopy screenings without cost sharing. In 2016, CMS issued guidance clarifying that bowel preparations are included under this requirement. However, many health plans are not adhering to this policy. We have been engaging with Congress to support a Congressional letter urging CMS to clarify that all FDA-approved bowel preparations must be covered. Meetings were also held with the relevant agencies to directly advocate for this change.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2024 · fourth_quarter · Q4
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 10545, American Relief Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2024 · fourth_quarter · Q4
H.R.4531 - Support for Patients and Communities Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2024 · third_quarter · 3@
FDAs psychedelic therapy clinical trial guidance, DEA/FDA policies related to clinical trials involving controlled substances, DEA Controlled Substances Scheduling policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2024 · third_quarter · 3T
FDAs psychedelic therapy clinical trial guidance, DEA/FDA policies related to clinical trials involving controlled substances, DEA Controlled Substances Scheduling policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEBELA PHARMACEUTICALS via THE KPM GROUP DC LLC
2024 · third_quarter · Q3
Affordable Care Acts Preventative Services Coverage mandate requires ACA compliant health plans to cover colonoscopy screenings without cost sharing . In 2016, CMS released guidance clarifying that bowel preps are included in that requirement. Health plans havent been following the low and have been engaging with Congress on a Congressional letter urging CMS to act by clarifying that all FDA approved bowel preps need to be covered. We all met with the listed agencies and asked for the change directly.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2024 · third_quarter · Q3
S.4426, Promising Pathway Act 2.0 H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4758/S.2372, Accelerating Kids Access to Care Act H.R.3433, the Give Kids a Chance Act H.R. 7623, Telehealth Modernization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2024 · third_quarter · Q3
H.R. 7623, Telehealth Modernization Act
Filing targets: HOUSE OF REPRESENTATIVES
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2024 · third_quarter · Q3
FDAs psychedelic therapy clinical trial guidance, DEA/FDA policies related to clinical trials involving controlled substances, DEA Controlled Substances Scheduling policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2024 · third_quarter · Q3
H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0 H.R. 4758, Accelerating Kids Access to Care Act H.R. 6664, Innovation in Pediatric Drugs Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R.9029 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2024 · first_quarter · Q1
H.R. 7384, Creating Hope Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2023 · third_quarter · 3A
FDA matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2023 · third_quarter · 3A
FDA Matters
Filing targets: SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
S. 1906 Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
HR 5894, the Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies bill; Improving Measurements for Loneliness and Isolation Act
Filing targets: HOUSE OF REPRESENTATIVES
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
Introductory Meetings
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
FDA Matters
Filing targets: SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
FDA matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
Minority Fellowship Program, Indian Health Service use of occupational series code for counselors
Filing targets: SENATE
SEBELA PHARMACEUTICALS via THE KPM GROUP DC LLC
2023 · fourth_quarter · RR
general healthcare issues; coverage for prescription bowel prep products
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
FDA Modernization - Senate HELP Minority
Filing targets: SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
Company introductions, FDA matters, Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIND MEDICINE INC. via THE KPM GROUP DC LLC
2023 · second_quarter · RR
HCR, FDA, DEA, psychedelic treatments, mental health
HCR, FDA, DEA, psychedelic treatments, mental health
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
Company introductions, comment letter
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
Implementation of Mental Health Access and Improvement Act of 2022 (H.R.432/S.868) (117th)
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2023 · first_quarter · RR
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development Neurology Drug Program
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development Neurology Drug Program
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2022 · fourth_quarter · 4@
Affordable Insulin Now Act, INSULIN Act, Inflation Reduction Act, Seniors Timely Access to Care Act (H.R.3173)
Filing targets: Federal Trade Commission (FTC), SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2022 · second_quarter · 2A
H.R. 432/S. 828 The Mental Health Access Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2022 · second_quarter · 2A
Affordable Insulin Now Act
Filing targets: SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
H.R. 432/S. 828 The Mental Health Access Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2022 · fourth_quarter · 4T
Affordable Insulin Now Act, INSULIN Act, Inflation Reduction Act, Seniors Timely Access to Care Act (H.R.3173)
Filing targets: Federal Trade Commission (FTC), SENATE
OPIANT PHARMACEUTICALS via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
SOR grant language changes, allowable expenses under the SOR grant
Filing targets: Health & Human Services, Dept of (HHS)
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
H.R. 432 The Mental Health Access Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
Affordable Insulin Now Act, INSULIN Act, Inflation Reduction Act, Seniors Timely Access to Care Act (H.R.3173)
Filing targets: Federal Trade Commission (FTC), SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
H.R. 432/S. 828 The Mental Health Access Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
Affordable Insulin Now Act
Filing targets: SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
H.R. 432/S. 828 The Mental Health Access Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
Company Drug Development Updates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
Affordable Insulin Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act H.R. 6000, Cures 2.0 Act H.R. 2623, Camerons Law H.R. 482/S. 350, the Newborn Screening Saves Lives Reauthorization Act
Orphan Drug Tax Credit Accelerated Approval Pathway
Medicare Negotiation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
Company Drug Approval Updates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPIANT PHARMACEUTICALS via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
Substance Abuse Treatment
Filing targets: Substance Abuse & Mental Health Services Administration (SAMHSA)
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 432/S. 828 The Mental Health Access Improvement Act, S. 3293 Post 9/11 Mental Health Access Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COGNOA, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
Market Access and Reimbursement Pediatric Behavioral Health Autism Spectrum Disorder (ASD) Digital Therapeutics/Digital Health AI/ML/IP in Healthcare Clinical Practice Guidelines (CPG) Tricare Comprehensive Autism Care Demonstration (military health)
RELMADA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
mental and behavioral health policy proposals and CMS coverage
ZAMBON USA via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
Cures 2.0 (not introduced yet)
Burn Pits Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
Senate Finance Committee Drug Pricing Principles Orphan Drug Tax Credit
H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act Build Back Better Act Cures 2.0
Medicare Negotiation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
NIH/NeuroBioBank Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
CMS Medicare Part D Senior Savings Model
Filing targets: HOUSE OF REPRESENTATIVES
CHIESI USA, INC. via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
FDA Inspections
H.R. 1730/S. 670, the Speeding Therapy Access Today (STAT) Act H.R. 2623, Camerons Law MACPAC Accelerated Approval Pathway Recommendations Cures 2.0 (not introduced yet)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act H.R. 3783/S. 2013, the Medical Nutrition Equity Act of 2021 Cures 2.0 (not introduced yet)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
H.R. 482/ S. 350, the Newborn Screening Saves Lives Speeding Therapy Access Today (STAT) Act - H.R. 1730/S. 670 Ensuring Lasting Smiles Act H.R. 1916/S. 754 HEART Act of 2020 - H.R. 7567 Reauthorization Act Cures 2.0
Fairness in Orphan Drug Exclusivity Act S. 250 Senate Finance Committee Drug Pricing Principles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 482/ S.350, the Newborn Screening Saves Lives Reauthorization Act MACPAC Accelerated Approval Pathway Recommendations
Senate Finance Committee Drug Pricing Principles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
Adding mental health counselors as an eligible provider of psychotherapy services under Medicare Part B Increase hiring of mental health counselors by the Department of Veteran's Affairs Increasing funding for SAMHSA's Minority Fellowship Program Ensuring the inclusion of counselors in telehealth measures
Adding mental health counselors as an eligible provider of psychotherapy services under Medicare Part B Increase hiring of mental health counselors by the Department of Veteran's Affairs Increasing funding for SAMHSA's Minority Fellowship Program Ensuring the inclusion of counselors in telehealth measures
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · first_quarter · RR
Treatment of rare diseases.
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics
Filing targets: HOUSE OF REPRESENTATIVES
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · second_quarter · RR
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2021 · second_quarter · RR
Discuss mission to raise awareness for brain donation; increased funding for NIH
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
FDA Foreign Inspections Backlog
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
CMS Medicare Part D Senior Savings Model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAMBON USA via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
Introductory Meeting; Burn Pits Legislation
Filing targets: HOUSE OF REPRESENTATIVES
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act H.R. 1916/S.754, Ensuring Lasting Smiles Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act Cures 2.0 (not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE